I could see a small country putting up 10 - 50 million for an option to purchase first delivery of Afrezza upon approval at a deep discount. But to loan or pre-purchase $200 million is a bit preposturous. If they put up $200 and Afrezza is never approved, they can either walk away (and be held accountable for losing $200 million) or they can take delivery (and be held accountable if patients have negative reaction). Who would take such a risk and why?